The Trouble With America’s Ultra-Processed Diet
Listen to article(2 minutes)Should your granola bar come with a warning label?Concern is rising about the amount of ultra-processed foods...
Cancer
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
Blood-Test Customers Mistakenly Told They May Have Cancer
Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch. Source link
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
HealthIn temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved...
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
WSJ News Exclusive | Johnson & Johnson’s Talc Plan Spotlights Chapter 11 Voting Power
Johnson & Johnson’s latest plan to resolve mass cancer lawsuits through bankruptcy could force some cosmetic-talc users and their lawyers...
J&J’s Talc Bankruptcy Case Thrown Out by Appeals Court
A federal appeals court in Philadelphia rejected Johnson & Johnson ‘s use of chapter 11 bankruptcy to freeze roughly 40,000...
Bayer Hits Courtroom Winning Streak as It Battles Remaining Roundup Lawsuits
Bayer AG BAYRY 3.28% is on a winning streak as it battles the remaining cases targeting its Roundup weedkiller, a...
Illumina Wins Case Against FTC on Grail Acquisition
An administrative law judge has ruled in favor of Illumina Inc. ILMN -2.10% in its $7.1 billion acquisition of cancer-testing...
WSJ News Exclusive | Merck Deal for Seagen Seen as Unlikely by Earnings Release
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s...
WSJ News Exclusive | Merck Explores Purchase of Biotech Seagen
Merck MRK -0.32% & Co. is eyeing a purchase of biotech Seagen Inc., SGEN 12.72% according to people familiar with...
Bristol-Myers to Buy Turning Point Therapeutics for $4.1 Billion
Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...
Fashion Designer Virgil Abloh Dies of Cancer at Age 41
PARIS—Virgil Abloh, the U.S. designer who championed streetwear and hip-hop culture in luxury fashion as one of the industry’s most...
Hasbro Enters Holiday Season With CEO on Health Leave
Hasbro Inc.’s HAS -1.62% abrupt leadership change this week leaves the toy company in the hands of lieutenants to navigate...
Sleep Apnea Sufferers Scramble After Philips Recall of Critical Machine
Aaron Horton, a sleep apnea sufferer, stops breathing for brief periods hundreds of times every night. To keep his oxygen...
